Institute of Human Virology

Name

Institute of Human Virology

Legal name

Institute of Human Virology

Website

https://ihv.org

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

251–500 employees

Ownership category

akta.pro rank

Product category

Infectious Disease Clinical Research and Care

NAICS

Medical Laboratories (621511), Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

General Infectious Disease (HLAKAGAA)

akta.pro secondary industries

HIV/AIDS Medicine (HLAKAGAB), Hepatology (Viral Hepatitis) (HLAKAGAC), Sexually Transmitted Infections (STI) (HLAKAGAI)

Keywords

• HIV clinical research
• Infectious disease treatment
• Viral disease prevention
• Medical research institute
• Harm reduction services

Headquarters

HQ city

Baltimore

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Grant Funding (Government and Foundation): Funding received from external programs such as Project IMPACT (City of Baltimore high-impact prevention), ViiV ACCELERATE! (Baltimore-based learning community), and the University of Maryland College Park Institute for Clinical and Translational Research (ICTR). Non-recurring/cyclical grant-based capital supporting specific initiatives.
2. Philanthropic Donations: Donations accepted through GiveCampus campaign platform for both IHV and the broader University of Maryland School of Medicine. One-time and recurring contributions from individuals and organizations.
3. Clinical Service Revenue: Revenue from clinical care delivery including general wellness, HIV prevention and treatment, Hepatitis C treatment, gender-affirming care, and harm reduction services delivered through the clinic at 725 W Lombard St and via telehealth. Mixed insurance, public payer, and free-of-charge service mix.
4. Research Funding (Institutional): Funding as part of the University of Maryland School of Medicine supporting virology, pathogenesis and cancer, vaccine research, immunotherapy, and epidemiology and prevention research programs.

Pricing tiers

Go-to-market motion4 records

Distribution channels6 records

Marketing channels6 records

Core offering

The Institute of Human Virology is a research institute and clinical care provider within the University of Maryland School of Medicine. It conducts basic-science, population, and clinical research in virology, pathogenesis, cancer, vaccine development, immunotherapy, and epidemiology, while operating clinical programs that deliver HIV prevention and treatment, Hepatitis C care, gender-affirming services, and harm reduction services to patients in Baltimore and internationally. Its community-facing arm, the JACQUES Initiative, provides free rapid testing, care navigation, and outreach programs.

Product overview

Institute of Human Virology (IHV) is a research institute of the University of Maryland School of Medicine operating a multi-program portfolio that combines basic-science research, clinical care delivery, education, and global health. It is anchored by the JACQUES Initiative, which functions as IHV's community-facing sub-brand delivering HIV/HCV testing, prevention (PrEP/PEP), treatment adherence, gender affirming care, harm reduction, and care navigation to approximately 5,000 patients through six Baltimore-area clinics. IHV's research divisions include Virology, Pathogenesis and Cancer (VPC), Vaccine Research, Immunotherapy, and Epidemiology & Prevention, while its clinical services span Community-Based Care, Surgical and Critical Care Infectious Diseases, Infectious Diseases in Immune Compromised Patients, the THRIVE HIV care program, and the ASCOT antimicrobial stewardship program. Specialized JACQUES programs include BOYZ NITE (transmasculine health), Face Your Fierce (transfeminine health), Tea Talk (Black women's sexual wellness), the SOAR returning citizens program, and the Hepatitis ReLink implementation science project. The offerings together form a research-to-clinic-to-community platform rather than a single unified product.

Differentiator

Problem solved

Functional benefit

Brands

• JACQUES Initiative: A program of the Institute of Human Virology at the University of Maryland School of Medicine, providing HIV and Hepatitis C clinical care, community outreach, harm reduction services, treatment navigation, education and engagement.

Products and services

• JACQUES Initiative Community-facing program delivering HIV and Hepatitis C testing, prevention, education, linkage to care, and supportive services to approximately 5,000 patients through six Baltimore-area clinics.
• HIV Prevention (PrEP/PEP) HIV prevention services offering oral (daily pill) and injectable (every-other-month shot) PrEP, both reported 99% effective in preventing HIV when taken as prescribed, plus PEP initiated within 72 hours of potential exposure.
• Hepatitis C (HCV) Treatment Specialty clinic offering HCV testing, liver health review, vaccinations for Hepatitis A and B, and 8-12 week curative treatments, plus Hepatitis C Test & Cure services at partner locations BD Health and Paul's Place in Baltimore City.
• Gender Affirming Care Comprehensive gender-affirming care for individuals 18+ following WPATH standards, including Gender Affirming Hormone Therapy, Letters for Name/Gender Change, and Referrals and Supporting Documentation to Gender Affirming Surgery.
• Harm Reduction Services Harm reduction services including Overdose Response Program (Naloxone and fentanyl/xylazine test strip distribution), smoking cessation support, alcohol use evaluation and treatment, HIV prevention, Hepatitis C treatment, and wound care.
• Rapid HIV and Hepatitis Testing Quick and confidential HIV and Hepatitis C testing with results in 20 minutes, plus linkage to medical services, HIV prevention services (PrEP & PEP), sexual health education, free condom distribution, and personalized prevention kits at the JACQUES Journey Center.
• Overdose Response Program Designated Maryland Overdose Response Program providing overdose prevention education and training, dispensing Naloxone to reverse opioid overdoses, and distributing free fentanyl and xylazine test strips.
• General Wellness & Sexual Health Clinical service providing health screenings (cancer, mental health, HIV/HCV), reproductive health, family planning, STI testing and prevention (PrEP, PEP, DoxyPEP), gender-affirming care, and HIV care with LGBTQIA+ cultural competency.
• HIV Linkage to Care Program Program supporting people living with HIV in accessing needed care through patient navigators and nurse care coordinators, including help identifying doctors, transportation, scheduling, primary care, mental health, addiction services, housing, and insurance assistance.
• Returning Citizens (SOAR) Program Support Outreach And Re-entry (SOAR) program in which JACQUES navigators work with the Department of Corrections to assist returning citizens living with HIV to access medical care and other supportive services.
• BOYZ NITE Transmasculine Health Celebration Transmasculine health celebration series providing a space for transmasculine individuals to access critical health services, celebrate gender joy, and form community, featuring DIY crafts, fitness, journaling, and health resources.
• Face Your Fierce Transfeminine Health Celebration Health celebration for transgender women combining resource fair, support group, and beauty class to celebrate beauty and strength of transfeminine people.
• Tea Talk Sexual Wellness Initiative Sexual health education initiative collaboratively developed by Black beauty industry professionals in Baltimore to promote knowledge about sexual wellness among Black women in Baltimore City, addressing HIV disparities through salon-based outreach.
• Virology, Pathogenesis and Cancer (VPC) Research Research program at IHV focused on virology, pathogenesis, and cancer-related studies.
• Vaccine Research Research program focused on vaccine development for HIV/AIDS and related infectious diseases.
• Immunotherapy Research Research division focused on immunotherapy approaches for viral diseases and cancer.
• Epidemiology & Prevention Research Research program focused on epidemiology and prevention of HIV/AIDS and other infectious diseases.
• Community-Based Clinical Care Clinical service delivering community-based infectious disease treatment across specialties including surgical infectious diseases, critical care infectious diseases, and infectious diseases in immunocompromised patients.
• Expert HIV Care (THRIVE Program) Expert HIV care program offering same-day walk-in services through the Connect 2 Care model.
• AIDS Education & Training Center (AETC) Professional education and training program on HIV/AIDS care for healthcare providers.

Quantifiable outcome

• Serves approximately 5,000 patients through six Baltimore-area clinics and more than 500,000 patients in seven African and two Caribbean nations
• +5 more outcomes

Segments7 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Partnerships

Eight partnerships are on record, tiered moderate, core, minor and flagship.

• University of Maryland College Park Institute for Clinical and Translational Research (ICTR)moderateStrategic or Co-development PartnerICTR is acknowledged as a supporting institution for the Sexual Health in Black Hair Salons project (JACQUES Initiative x HAIR collaboration). ICTR enables the university research infrastructure that underpins the project.
• HAIR (Health Advocates In-Reach and Research)coreStrategic or Co-development PartnerJACQUES has partnered with HAIR (Health Advocates In-Reach and Research), a community of owner-operator stylists and entrepreneurs from Black owner-operator salons who engage in health education and promotion activities. The collaboration engages stylists as experts in codesigning a sexual health curriculum including PrEP education, forming a community of practice among like-minded stylists.
• University of Maryland Medical SystemcoreStrategic or Co-development PartnerThe Hepatitis ReLink Project (Relink Project) collaborates with the University of Maryland Medical System to analyze eight years of patient records, identifying and reaching individuals who may be unaware they are living with Hepatitis B or C. Patient Navigators call patients, provide education on diagnosis, offer provider scheduling and social resources, and conduct follow-up calls to ensure linkage to care.
• Maryland Department of CorrectionsmoderateImplementation/ SI/ Consulting PartnerThrough the Support Outreach And Re-entry (SOAR) program, JACQUES Initiative navigators work with the Department of Corrections to assist returning citizens living with HIV to access medical care and other supportive services.
• BD HealthminorChannel Partner/ Reseller/ DistributorPartner location in Baltimore City where JACQUES Initiative provides Hepatitis C Test & Cure services in the community.
• Paul's PlaceminorChannel Partner/ Reseller/ DistributorPartner location in Baltimore City where JACQUES Initiative provides Hepatitis C Test & Cure services in the community.
• University of Maryland School of MedicineflagshipStrategic or Co-development PartnerThe Institute of Human Virology is a research institute within the University of Maryland School of Medicine. IHV is the first research institute in the U.S. to link basic science, population studies, and clinical trials to develop new vaccines and treatments for HIV/AIDS.
• University of Maryland, Baltimore (UMB)flagshipStrategic or Co-development PartnerThe JACQUES Initiative (and by extension IHV) is hosted at UMB. UMB provides the academic, administrative, and infrastructural umbrella under which IHV operates and lists IHV as an affiliated institute.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Fenway Health: Boston-based LGBTQ+ community health center with deep HIV/AIDS, gender-affirming, and harm-reduction service lines; operates research division (Fenway Institute) that mirrors IHV's translational research integration.
• Whitman-Walker Health: Washington D.C.-based community health center providing HIV/AIDS care, PrEP/PEP, gender-affirming care, and LGBTQ+ primary care — directly comparable to JACQUES Initiative's service mix and patient population.
• Callen-Lorde Community Health Center: New York City-based LGBTQ+ health center offering HIV prevention/treatment, gender-affirming care, and community outreach — directly comparable to JACQUES Initiative's clinical and community programming.
• Howard Brown Health: Chicago-based LGBTQ+ health organization with HIV care, PrEP, gender-affirming services, and research — comparable in service breadth and underserved-population focus to IHV/JACQUES.
• Johns Hopkins HIV Clinical Program: Baltimore-based academic HIV clinical and research program at Johns Hopkins — directly comparable to IHV's translational HIV research and clinical care, and based in the same metro market where IHV's medical director was trained.
• Chase Brexton Health Care: Baltimore-based community health system providing HIV care, LGBTQ+ primary care, and behavioral health — a direct geographic and service-line peer operating in the same Baltimore metro market.
• San Francisco AIDS Foundation (SFAF): San Francisco-based HIV/AIDS services organization delivering testing, PrEP, harm reduction, and community programs — directly comparable to JACQUES Initiative's community-facing HIV portfolio.

Broad incumbents

• University of California San Francisco (UCSF) HIV Clinical Trials Unit: Major academic HIV clinical trials and research program — comparable translational research and clinical trial integration to IHV, but operating at significantly larger scale as a UC system flagship.
• AIDS Healthcare Foundation (AHF): Largest global AIDS organization operating HIV clinics, testing, and pharmacy services in 45+ countries — comparable global footprint and HIV clinical focus, but operates as a broader incumbent rather than a research-anchored institute.
• Emory Center for AIDS Research (CFAR): NIH-funded academic HIV research center at Emory University integrating basic science and clinical trials — comparable translational HIV research profile to IHV's research divisions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/IHVmaryland
• YouTubeyoutube.com/channel/UCr-b1Sh1TpGEum86wvRB-wg
• Facebookfacebook.com/IHVmaryland
• LinkedInlinkedin.com/company/institute-of-human-virology-university-of-maryland-school-of-medicine

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute of Human Virology